z-logo
open-access-imgOpen Access
Statins & risk of Clostridium difficile infection: A meta-analysis
Author(s) -
Karn Wijarnpreecha,
Panadeekarn Panjawatanan,
Charat Thongprayoon,
Patompong Ungprasert
Publication year - 2019
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_1973_17
Subject(s) - clostridium difficile , medicine , microbiology and biotechnology , clostridium , meta analysis , intensive care medicine , antibiotics , biology , bacteria , genetics
Clostridium difficile infection is one of the most common healthcare-associated infections worldwide. Recent epidemiologic studies have suggested that statin users may have a lower risk of C. difficile infection, although the results are inconsistent. This meta-analysis was conducted with the aim of summarizing all available data to assess the risk of C. difficile infection among statin users versus non-users.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here